Pediatrics

Findings show that children in early childhood are not completing their multidose vaccine series due to some structural barriers.

The US Preventive Task Force (USPSTF) released its updated recommendations for screening children and adolescents for lipid disorders.

The American Academy of Pediatrics has released new recommendations on screening for HIV in certain patient populations.

The randomized, placebo-controlled, double-masked clinical trial included 187 children aged 5 to 12 years with low-to-moderate myopia.

The FDA approved the new round of vaccines for those 12 years and older and authorized emergency use for children 6 months to 11 years of age.

The American Heart Association released a new scientific statement on the key principles in personalized treatment strategies for children with cardiomyopathy.

In this Roundtable Wrap-Up, we offer an abbreviated version of the roundtable discussion on the evaluation, treatment, and management of patients with moderate-to-severe atopic dermatitis.

Earlier this year, the FDA approved the same vaccine for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.

The FDA has approved empagliflozin, and empagliflozin and hydrochloride to help manage type 2 diabetes in pediatric patients.

Following three clinical trials, the FDA has approved a new preventive treatment for neonates, infants, and toddlers that prevents respiratory syncytial virus (RSV) in those age populations.